These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26077250)

  • 1. Microplate-based assay for identifying small molecules that bind a specific intersubunit interface within the assembled HIV-1 capsid.
    Halambage UD; Wong JP; Melancon BJ; Lindsley CW; Aiken C
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5190-5. PubMed ID: 26077250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A HTRF based competitive binding assay for screening specific inhibitors of HIV-1 capsid assembly targeting the C-Terminal domain of capsid.
    Zhang DW; Luo RH; Xu L; Yang LM; Xu XS; Bedwell GJ; Engelman AN; Zheng YT; Chang S
    Antiviral Res; 2019 Sep; 169():104544. PubMed ID: 31254557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ebselen, a Small-Molecule Capsid Inhibitor of HIV-1 Replication.
    Thenin-Houssier S; de Vera IM; Pedro-Rosa L; Brady A; Richard A; Konnick B; Opp S; Buffone C; Fuhrmann J; Kota S; Billack B; Pietka-Ottlik M; Tellinghuisen T; Choe H; Spicer T; Scampavia L; Diaz-Griffero F; Kojetin DJ; Valente ST
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2195-208. PubMed ID: 26810656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific Inhibitors of HIV Capsid Assembly Binding to the C-Terminal Domain of the Capsid Protein: Evaluation of 2-Arylquinazolines as Potential Antiviral Compounds.
    Machara A; Lux V; Kožíšek M; Grantz Šašková K; Štěpánek O; Kotora M; Parkan K; Pávová M; Glass B; Sehr P; Lewis J; Müller B; Kräusslich HG; Konvalinka J
    J Med Chem; 2016 Jan; 59(2):545-58. PubMed ID: 26685880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of HIV-1 Maturation via Small-Molecule Targeting of the Amino-Terminal Domain in the Viral Capsid Protein.
    Wang W; Zhou J; Halambage UD; Jurado KA; Jamin AV; Wang Y; Engelman AN; Aiken C
    J Virol; 2017 May; 91(9):. PubMed ID: 28202766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a small molecule HIV-1 inhibitor that targets the capsid hexamer.
    Xu JP; Branson JD; Lawrence R; Cocklin S
    Bioorg Med Chem Lett; 2016 Feb; 26(3):824-828. PubMed ID: 26747394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationally designed interfacial peptides are efficient in vitro inhibitors of HIV-1 capsid assembly with antiviral activity.
    Bocanegra R; Nevot M; Doménech R; López I; Abián O; Rodríguez-Huete A; Cavasotto CN; Velázquez-Campoy A; Gómez J; Martínez MÁ; Neira JL; Mateu MG
    PLoS One; 2011; 6(9):e23877. PubMed ID: 21931621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural-product-library-based screening for discovery of capsid C-terminal domain targeted HIV-1 inhibitors.
    Zhang DW; Luo RH; Xu L; Yang LM; Xu XS; Zheng YT; Luo H
    Int J Antimicrob Agents; 2020 Apr; 55(4):105926. PubMed ID: 32092396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of dual inhibitors targeting both HIV-1 capsid and human cyclophilin A to inhibit the assembly and uncoating of the viral capsid.
    Li J; Tan Z; Tang S; Hewlett I; Pang R; He M; He S; Tian B; Chen K; Yang M
    Bioorg Med Chem; 2009 Apr; 17(8):3177-88. PubMed ID: 19328002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical targeting of HIV capsid protein with a long-acting small molecule.
    Link JO; Rhee MS; Tse WC; Zheng J; Somoza JR; Rowe W; Begley R; Chiu A; Mulato A; Hansen D; Singer E; Tsai LK; Bam RA; Chou CH; Canales E; Brizgys G; Zhang JR; Li J; Graupe M; Morganelli P; Liu Q; Wu Q; Halcomb RL; Saito RD; Schroeder SD; Lazerwith SE; Bondy S; Jin D; Hung M; Novikov N; Liu X; Villaseñor AG; Cannizzaro CE; Hu EY; Anderson RL; Appleby TC; Lu B; Mwangi J; Liclican A; Niedziela-Majka A; Papalia GA; Wong MH; Leavitt SA; Xu Y; Koditek D; Stepan GJ; Yu H; Pagratis N; Clancy S; Ahmadyar S; Cai TZ; Sellers S; Wolckenhauer SA; Ling J; Callebaut C; Margot N; Ram RR; Liu YP; Hyland R; Sinclair GI; Ruane PJ; Crofoot GE; McDonald CK; Brainard DM; Lad L; Swaminathan S; Sundquist WI; Sakowicz R; Chester AE; Lee WE; Daar ES; Yant SR; Cihlar T
    Nature; 2020 Aug; 584(7822):614-618. PubMed ID: 32612233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel small-molecule HIV-1 replication inhibitors that stabilize capsid complexes.
    Lamorte L; Titolo S; Lemke CT; Goudreau N; Mercier JF; Wardrop E; Shah VB; von Schwedler UK; Langelier C; Banik SS; Aiken C; Sundquist WI; Mason SW
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4622-31. PubMed ID: 23817385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Small-Molecule Anti-HIV-1 Agents Targeting HIV-1 Capsid Proteins.
    Kobayakawa T; Yokoyama M; Tsuji K; Boku S; Kurakami M; Fujino M; Ishii T; Miura Y; Nishimura S; Shinohara K; Yamamoto K; Bolah P; Kotani O; Murakami T; Sato H; Tamamura H
    Chem Pharm Bull (Tokyo); 2024; 72(1):41-47. PubMed ID: 38171903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-HIV agents that selectively target retroviral nucleocapsid protein zinc fingers without affecting cellular zinc finger proteins.
    Huang M; Maynard A; Turpin JA; Graham L; Janini GM; Covell DG; Rice WG
    J Med Chem; 1998 Apr; 41(9):1371-81. PubMed ID: 9554870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of clickable HIV-1 capsid-targeting probes for viral replication inhibition.
    McFadden WM; Casey-Moore MC; Bare GAL; Kirby KA; Wen X; Li G; Wang H; Slack RL; Snyder AA; Lorson ZC; Kaufman IL; Cilento ME; Tedbury PR; Gembicky M; Olson AJ; Torbett BE; Sharpless KB; Sarafianos SG
    Cell Chem Biol; 2024 Mar; 31(3):477-486.e7. PubMed ID: 38518746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 capsid variability: viral exploitation and evasion of capsid-binding molecules.
    Saito A; Yamashita M
    Retrovirology; 2021 Oct; 18(1):32. PubMed ID: 34702294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of the HIV-1 capsid, a target of opportunity.
    Carnes SK; Sheehan JH; Aiken C
    Curr Opin HIV AIDS; 2018 Jul; 13(4):359-365. PubMed ID: 29782334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical profiling of HIV-1 capsid-targeting antiviral PF74.
    Wang L; Casey MC; Vernekar SKV; Do HT; Sahani RL; Kirby KA; Du H; Hachiya A; Zhang H; Tedbury PR; Xie J; Sarafianos SG; Wang Z
    Eur J Med Chem; 2020 Aug; 200():112427. PubMed ID: 32438252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 capsid protein and cyclophilin a as new targets for anti-AIDS therapeutic agents.
    Li J; Tang S; Hewlett I; Yang M
    Infect Disord Drug Targets; 2007 Sep; 7(3):238-44. PubMed ID: 17897064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting early-stage events in HIV-1 replication by small-molecule targeting of the HIV-1 capsid.
    Kortagere S; Madani N; Mankowski MK; Schön A; Zentner I; Swaminathan G; Princiotto A; Anthony K; Oza A; Sierra LJ; Passic SR; Wang X; Jones DM; Stavale E; Krebs FC; Martín-García J; Freire E; Ptak RG; Sodroski J; Cocklin S; Smith AB
    J Virol; 2012 Aug; 86(16):8472-81. PubMed ID: 22647699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of phenylalanine derivatives as potent HIV-1 capsid inhibitors from click chemistry-based compound library.
    Wu G; Zalloum WA; Meuser ME; Jing L; Kang D; Chen CH; Tian Y; Zhang F; Cocklin S; Lee KH; Liu X; Zhan P
    Eur J Med Chem; 2018 Oct; 158():478-492. PubMed ID: 30243152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.